3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Pain
1
Neuroblastoma
1
Melanoma
1
Leukemia, Hairy Cell
1
Ganglioneuroblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
Capecitabine
22
Oxaliplatin
19
Fluorouracil
16
Radiotherapy
11
Leucovorin
10
Cetuximab
9
Nivolumab
7
Bevacizumab
6
sintilimab
5
Specimen Handling
5
Radiotherapy, Intensity-Modulated
5
Magnetic Resonance Spectroscopy
5
Irinotecan
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
pembrolizumab
4
Surgical Procedures, Operative
4
encorafenib
3
X-Rays
3
Trastuzumab
3
Surveys and Questionnaires
3
Sigmoidoscopy
3
Radiation
3
Pemetrexed
3
Gemcitabine
3
Endoscopy
3
Control Groups
3
Consolidation Chemotherapy
3
Cisplatin
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
High-Energy Shock Waves
×
90 days
×
Clear all
No trials found.